betamethasone oral mucosal spray (GTX-102)
/ Grace Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 23, 2023
Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=48 | Active, not recruiting | Sponsor: Acasti Pharma Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: Nov 2022 ➔ May 2023
Enrollment closed • Trial completion date • Ataxia • Immunology • Movement Disorders • Primary Immunodeficiency
September 08, 2022
Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Acasti Pharma Inc.
New P1 trial • Ataxia • Immunology • Movement Disorders • Primary Immunodeficiency
1 to 2
Of
2
Go to page
1